Elsevier期刊
期刊
会议
图书
作者:Umesh D. Parashar , Jacqueline E. Tate ...
来源:[J].Vaccine(IF 3.492), 2017
摘要:Abstract(#br)Background(#br)Acute gastroenteritis (AGE) is a leading cause of morbidity and mortality among children <5 years of age in developing countries, with rotavirus being the most common infectious etiology. In November 2014, monovalent rotavirus vaccine was introduc...
作者:... Baoming Jiang , Umesh D. Parashar , Zhao-jun Duan
来源:[J].Vaccine(IF 3.492), 2018
摘要:Abstract(#br)Introduction(#br)In China, rotavirus is the leading cause of diarrhea hospitalizations among children aged <5 years. A locally manufactured rotavirus vaccine is available for private market use, but little is known about its coverage. Given the impending availab...
作者:... Stephen P. Luby , Emily S. Gurley , Umesh D. Parashar
来源:[J].Vaccine(IF 3.492), 2018
摘要:Abstract(#br)Introduction(#br)In preparation for the introduction of a rotavirus vaccine into the routine immunization program of Bangladesh in 2018, we report data and highlight evolving genotypes from five years of active hospital-based rotavirus surveillance which began in Jul...
作者:... Jacqueline E. Tate , Umesh D. Parashar , Anjana Karki Rayamajhi
来源:[J].Vaccine(IF 3.492), 2017
摘要:Abstract(#br)Background(#br)Rotavirus is the most common cause of severe diarrhea in Nepali children, accounting for 25–33% of childhood diarrhea hospitalizations. Two rotavirus vaccines recommended for inclusion in national immunization programs have been associated with a ...
作者:... Jacqueline E. Tate , Meng Shi , Umesh D. Parashar
来源:[J].Vaccine(IF 3.492), 2019, Vol.37 (24), pp.3229-3233
摘要:Abstract(#br)Background(#br)Rotavirus is the leading cause of severe diarrhea among children worldwide, and vaccines can reduce morbidity and mortality by 50–98%. The test-negative control (TNC) study design is increasingly used for evaluating the effectiveness of vaccines a...
作者:Umesh D. Parashar , Jacqueline E. Tate ...
来源:[J].Vaccine(IF 3.492), 2018, Vol.36 (2), pp.273-279
摘要:Abstract(#br)Background(#br)Strategies are needed to improve oral rotavirus vaccine (RV), which provides suboptimal protection in developing countries. Probiotics and zinc supplementation could improve RV immunogenicity by altering the intestinal microbiota and immune functi...
作者:... Goitom G. Weldegebriel , Umesh D. Parashar , Jacqueline E. Tate
来源:[J].Vaccine(IF 3.492), 2017
摘要:Abstract(#br)Background(#br)Mozambique introduced rotavirus vaccine (Rotarix, GSK Biologicals) in the National Immunization Program in September 2015 with the objective of reducing the burden of total diarrheal disease and specifically severe rotavirus disease. This study ai...
作者:... Jeanine Uwimana , Umesh D. Parashar , Jacqueline E. Tate
来源:[J].Vaccine(IF 3.492), 2018
摘要:Abstract(#br)Background(#br)Rwanda introduced pentavalent rotavirus vaccine into its national immunization program in 2012. To determine the long-term impact of rotavirus vaccine on disease burden in a high burden setting, we examined trends in rotavirus and all-cause diarrh...
作者:... Jason M. Mwenda , Jacqueline E. Tate , Umesh D. Parashar
来源:[J].Vaccine(IF 3.492), 2017
摘要:Abstract(#br)Background(#br)Burkina Faso was one of the first African nations to introduce pentavalent rotavirus vaccine (RV5, RotaTeq) into its national immunization program in October 2013. We describe the impact and effectiveness of rotavirus vaccine on acute gastroenteri...
作者:... Dadja Landoh , Yawo Atakouma , Umesh D. Parashar
来源:[J].Vaccine(IF 3.492), 2018
摘要:Abstract(#br)Background(#br)Monovalent rotavirus vaccine (RV1) was introduced in the immunization schedule of Togo in June 2014. We evaluated the impact of rotavirus vaccines on acute gastroenteritis (AGE) and rotavirus-associated hospitalizations in Togolese children.(#br)M...

我们正在为您处理中,这可能需要一些时间,请稍等。

资源合作:cnki.scholar@cnki.net, +86-10-82896619   意见反馈:scholar@cnki.net

×